Pharmaron Beijing Sustainability Profile
Pharmaron Beijing Co., Ltd., commonly referred to as Pharmaron, is a leading contract research organisation (CRO) headquartered in Beijing, China. Established in 2004, the company has rapidly expanded its operational footprint across major regions, including North America and Europe, positioning itself as a key player in the pharmaceutical and biotechnology sectors. Pharmaron offers a comprehensive suite of services, including drug discovery, development, and manufacturing, with a focus on small molecules and biologics. Its unique integration of advanced technologies and scientific expertise enables clients to accelerate their drug development processes. Notably, Pharmaron has achieved significant milestones, such as successful collaborations with global pharmaceutical companies, solidifying its reputation for excellence in the industry. With a commitment to innovation and quality, Pharmaron continues to enhance its market position as a trusted partner in the life sciences arena.
DitchCarbon Score
How does Pharmaron Beijing's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmaron Beijing's score of 68 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmaron Beijing's reported carbon emissions
In 2024, Pharmaron Beijing reported total carbon emissions of approximately 34268000 kg CO2e for Scope 1, 164432780 kg CO2e for Scope 2, and 414817330 kg CO2e for Scope 3. The combined emissions for Scope 1 and 2 amounted to about 198700780 kg CO2e. In comparison, the previous year, 2023, saw emissions of approximately 34755680 kg CO2e for Scope 1, 216740300 kg CO2e for Scope 2, and 395142930 kg CO2e for Scope 3, with a total of about 251495980 kg CO2e for Scope 1 and 2. Pharmaron has set ambitious climate commitments, aiming to achieve near-zero emissions for both Scope 1 and Scope 2 by 2025. Additionally, they have pledged to reduce absolute Scope 1 and 2 emissions by 54.60% by 2033 from a 2023 base year and to reach net-zero greenhouse gas emissions across their value chain by 2050. For Scope 3 emissions, the company targets a reduction of 61.07% per million CNY value added by 2033, with a long-term goal of a 97% reduction by 2050. These targets align with the Science Based Targets initiative (SBTi) and reflect Pharmaron's commitment to sustainable practices within the pharmaceutical and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 48,007,050 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 267,941,280 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 |
How Carbon Intensive is Pharmaron Beijing's Industry?
How Carbon Intensive is Pharmaron Beijing's Location?
Pharmaron Beijing's Scope 3 Categories Breakdown
Pharmaron Beijing's Scope 3 emissions, which increased by 5% last year and increased by approximately 5% since 2023, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 68% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 55% of Scope 3 emissions.
Top Scope 3 Categories
Pharmaron Beijing's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmaron Beijing has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Hangzhou Tigermed
Frequently Asked Questions
Common questions about Pharmaron Beijing's sustainability data and climate commitments